WANY
INSM icon

Wealthspire Advisors (New York)’s Insmed INSM Stock Holding History

Wealthspire Advisors (New York)’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-58
Closed -$8.35K – 1937
2025
Q3 		$8.35K Buy
+58
New +$7.11K ﹤0.01% 2113

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wealthspire Advisors (New York)'s INSM Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Insmed (INSM) in Q4 2025, closing a stake of 58 shares — an estimated $8.35K sold.

Wealthspire Advisors (New York) first reported a position in INSM in Q3 2025 and held it in 1 quarter. The position peaked at $8.35K in Q3 2025. 677 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 58 Insmed shares in Q4 2025, an estimated $8.35K.
  • Wealthspire Advisors (New York) first reported a position in Insmed in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Insmed position peaked at $8.35K in Q3 2025.
  • 677 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.